Table 3.
Antimicrobial susceptibility test results of the 50 strains of carbapenem-resistant Enterobacteriaceae (CRE)
| Antibiotics | CRKP(n = 36) | CREC(n = 14) | ||||
|---|---|---|---|---|---|---|
| Resistant | Intermediate | Susceptible | Resistant | Intermediate | Susceptible | |
| ETP | 100% | 0 | 0 | 100% | 0 | 0 |
| IMP | 94.4% | 2.78% | 2.78% | 100% | 0 | 0 |
| FEP | 100% | 0 | 0 | 100% | 0 | 0 |
| CAZ | 100% | 0 | 0 | 100% | 0 | 0 |
| TZP | 100% | 0 | 0 | 100% | 0 | 0 |
| AMK | 86.1% | 0 | 13.9% | 92.9% | 0 | 7.14% |
| FOX | 100% | 0 | 0 | 100% | 0 | 0 |
| SAM | 100% | 0 | 0 | 100% | 0 | 0 |
| LEV | 94.5% | 0 | 5.55% | 85.7% | 0 | 14.3% |
| CIP | 97.2% | 0 | 2.78% | 85.7% | 0 | 14.3% |
| CTX | 100% | 0 | 0 | 100% | 0 | 0 |
| CRO | 100% | 0 | 0 | 100% | 0 | 0 |
ETP ertapenem, IMP imipenem, FEP cefepime, CAZ ceftazidime, TZP piperacillin-tazobactam, AMK amikacin, FOX cefoxitin, SAM ampicillin-sulbactam, LEV levofloxacin, CIP ciprofloxacin, CTX cefotaxime, CRO ceftriaxone